– Bloomberg News
Maravai LifeSciences Q3 Adj. EPS $0.37 Beats $0.33 Estimate, Sales $191.26M Miss $195.10M Estimate
Maravai LifeSciences (NASDAQ:MRVI) reported quarterly earnings of $0.37 per share which beat the analyst consensus estimate of $0.33 by 12.12 percent. This is a 15.91 percent decrease over earnings of $0.44 per share